CrisprBits Raises $250,000 in Pre-Seed Round from US-based VJ Group The funding will be utilized for product development, team expansion and for research and development

By Saptak Bardhan

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

CrisprBits

CrisprBits on Monday announced to have raised $250,000 in pre-seed funding from US-based VJ Group. The funding will be utilized for product development, team expansion and for research and development.

"CrisprBits was founded with an aim to address critical healthcare needs through the use of a breakthrough technology like CRISPR. The team's prior experience in developing diagnostics, precision medicine and clinical-research solutions that are used by clinicians, pharmaceutical and biotechnology companies in India and around the world, has enabled us to come out with products that have significant public health and social impact. The new investment will accelerate our next phase of growth and allow us develop many more high-quality healthcare solutions in diagnostics and gene editing," said Sunil Arora, co-founder and CEO, CrisprBits

"The potential of CRISPR technology is truly incredible, and we are excited to support CrisprBits harnessing this technology to develop high quality yet affordable and accessible solutions to improve human health. We look forward to working together to commercialize the products that are in the pipeline as well as develop new products. We strongly believe that this collaboration will lead to synergistic outcomes," said Vijay Alreja, founder and CEO, VJ Group.

Founded by Dr. Vijay Chandru, Sunil Arora, Dr. Rajeev Kohli, Bharat Jobanputra, and Aditya Sarda in 2020, CrisprBits was started with a vision of developing high-quality healthcare solutions in diagnostics and gene editing that all Indians can afford. The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial resistance genes associated with hospital-acquired infections. The company also developed OmiCrisp, a CRISPR- based test to detect SARS-CoV2 and to determine whether it is an Omicron or non-omicron variant. The test was developed with support and collaboration from the C-CAMP-InDx (Indigenisation of Diagnostics Program), an initiative supported by the Department of Biotechnology, Govt of India.

Saptak Bardhan

Former Trainee Writer

Former Trainee Writer
Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Side Hustle

'I Was Called Crazy': This 27-Year-Old's Side Hustle Hit $30,000 a Month in Under a Year — Now It's Worth Millions

Changing regulations forced Angel Rodriguez's jet ski rental company to shut down, and the young entrepreneur had to figure out his next move — fast.

Leadership

Why The Wisest Leaders Listen First Before They Act

If talking isn't getting you ahead, try listening instead. The advantages of truly hearing others are as transformational in business as they are in our personal lives.

Growing a Business

The 10 Best Podcasts Every Entrepreneur Should Listen to for Growth, Strategy and Success

Unlock your potential with the 10 must-listen podcasts for entrepreneurs, offering expert insights on growth, strategy and success.

Growing a Business

4 Advanced Marketing Tactics for Small Businesses That Actually Work

Small businesses can adopt advanced marketing strategies to stand out and achieve sustainable growth. Techniques like personalization, content clusters and virtual events help build stronger customer connections and deliver real results.

Science & Technology

Want to Make Money With AI? Here Are Easy Steps to Unlock Explosive Profits in 2025

Learn to turn Google AI Studio into a profit-boosting machine with this three-step framework. Train AI to analyze data, uncover sales opportunities and maximize profits.